Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

Queen's University (Kingston, Ontario)

$397,897.00

The role of microRNAs in Malignant Melanoma

EF 2008-09

Résumé
Malignant melanoma continues to rise in incidence. This deadly form of skin cancer remains poorly understood, with limited treatment options once the tumor spreads. microRNAs are short, non-coding RNA molecules which are known to regulate many cellular processes. We have discovered 9 dysregulated microRNA members in melanoma, and hypothesize that these 9 molecules plan a role in the pathogenesis of this cancer. We wish to examine the expression of our target 9 microRNAs in a large melanoma cohort to determine if they can predict clinical outcome. Furthermore, we would like to extend our preliminary findings by initially manipulating these selected 9 microRNA molecules in melanoma cell lines and determining if a biological effect can be shown. Finally, we would like to know why these molecules are dysregulated by studying the DNA in which these genes are located.
Programme
Operating Grant
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
178714
Name
Tron Victor A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Progression & Therapeutics
Projecttitle
The role of microRNAs in Malignant Melanoma
Programtype2
Operating Grants
Orgnameinp2
Queen's University (Kingston, Ontario)
Cihramount2
$397,897
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cell Biology; Melanoma; Microrna; Patient Outcome; Systemic Therapy
Abstract
Malignant melanoma continues to rise in incidence. This deadly form of skin cancer remains poorly understood, with limited treatment options once the tumor spreads. microRNAs are short, non-coding RNA molecules which are known to regulate many cellular processes. We have discovered 9 dysregulated microRNA members in melanoma, and hypothesize that these 9 molecules plan a role in the pathogenesis of this cancer. We wish to examine the expression of our target 9 microRNAs in a large melanoma cohort to determine if they can predict clinical outcome. Furthermore, we would like to extend our preliminary findings by initially manipulating these selected 9 microRNA molecules in melanoma cell lines and determining if a biological effect can be shown. Finally, we would like to know why these molecules are dysregulated by studying the DNA in which these genes are located.
Competitiondate
200903
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tron, Victor A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $397,897~ $0~